Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL35307 | 0.92 | — | — | |
| Acrylamide SCHEMBL7456424 | 0.90 | ALDH1A1 (0.52) | LMNAALOX15BLMPMP22ALDH1A1 | |
| SCHEMBL27670459 | 0.90 | ALDH1A1 (0.36) | ALDH1A1TSHRFGFR4 | |
| Acrylamide SCHEMBL29171645 | 0.88 | ALDH1A1 (0.50) | LMNAALOX15BLMPMP22ALDH1A1 | |
| Acetic Acid SCHEMBL7555401 | 0.86 | FFAR3 (0.39) | LMNAALDH1A1 | |
| Methacrylic Acid SCHEMBL10536704 | 0.80 | ALDH1A1 (0.33) | ALDH1A1TDP1 | |
| Acrylic Acid SCHEMBL5083639 | 0.78 | ALDH1A1 (0.38) | ALDH1A1 | |
| SCHEMBL2162008 | 0.78 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL28680465 | 0.78 | — | — | |
| SCHEMBL6943221 | 0.77 | ALDH1A1 (0.31) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130129657-A1 | SPRAYABLE COMPOSITION COMPRISING HIGH MOLECULAR WEIGHT CHARGED POLYMER | ISP INVESTMENTS INC. (US) | 2013-05-23 | — | — | US | claimed |
| EP-2555741-A1 | SPRAYABLE COMPOSITION COMPRISING HIGH MOLECULAR WEIGHT CHARGED POLYMER | ISP Investments Inc. (US) | 2013-02-13 | — | — | EP | claimed |
| WO-2011126978-A1 | SPRAYABLE COMPOSITION COMPRISING HIGH MOLECULAR WEIGHT CHARGED POLYMER | ISP INVESTMENTS INC. (US) | 2011-10-13 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130129657-A1 | SPRAYABLE COMPOSITION COMPRISING HIGH MOLECULAR WEIGHT CHARGED POLYMER | PARN, PARG, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | LMNA 4439/4885ALOX15 2882/4885BLM 1127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.